WELL Health Technologies (TSE:WELL) Hits New 12-Month High on Analyst Upgrade

WELL Health Technologies Corp. (TSE:WELL)’s stock price reached a new 52-week high on Tuesday after Royal Bank of Canada raised their price target on the stock from C$7.00 to C$8.50. The stock traded as high as C$7.30 and last traded at C$7.23, with a volume of 1354392 shares traded. The stock had previously closed at C$6.95.

WELL has been the topic of several other reports. Raymond James upped their price objective on shares of WELL Health Technologies from C$10.00 to C$11.00 in a report on Tuesday, December 17th. Scotiabank increased their price target on WELL Health Technologies from C$6.00 to C$7.00 in a research report on Monday, December 16th. TD Securities lifted their price objective on WELL Health Technologies from C$8.00 to C$8.50 in a research note on Tuesday, December 17th. Ventum Financial lowered their target price on WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating on the stock in a research note on Tuesday, October 29th. Finally, CIBC lifted their price target on WELL Health Technologies from C$5.25 to C$7.00 in a research report on Friday, December 13th.

WELL Health Technologies Trading Up 4.5 %

The company has a current ratio of 1.25, a quick ratio of 1.02 and a debt-to-equity ratio of 41.57. The company has a market capitalization of C$1.81 billion, a price-to-earnings ratio of 12.74, a PEG ratio of -1.93 and a beta of 1.20. The company has a fifty day moving average of C$5.99 and a 200-day moving average of C$5.05.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.